CLEMENTI, FRANCESCO
CLEMENTI, FRANCESCO
5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: synthesis of all the stereoisomers and alpha4beta2 nicotinic affinity.
2009 Pallavicini, M; Bolchi, C; Binda, M; Cilia, A; Clementi, F; Ferrara, R; Fumagalli, L; Gotti, C; Moretti, M; Pedretti, A; Vistoli, G; Valoti, E
A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes.
2010 Moretti M ; Mugnaini M; Tessari M ; Zoli M ; Gaimarri A; Manfredi I ; Pistillo F; Clementi F;Gotti C
alfa9- and alfa7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line
2018 Mucchietto, V; Fasoli, F; Pucci, S; Moretti, M; Benfante, R; Maroli, A; Di Lascio, S; Bolchi, C; Pallavicini, M; Dowell, C; Mcintosh, M; Clementi, F; Gotti, C
Brain neuronal nicotinic receptors as new targets for drug discovery.
2006 Gotti, C; Riganti, L; Vailati, S; Clementi, F
Brain nicotinic acetylcholine receptors: native subtypes and their relevance.
2006 Gotti C ; Zoli M ;Clementi F
CC4, a dimer of cytisine, is a selective partial agonist at alpha4beta2/alpha6beta2 nAChR with improved selectivity for tobacco smoking cessation
2013 Sala, Mariaelvina; Braida, Daniela; Pucci, Luca; Manfredi, Irene; J Marks, Michael; R Wageman, Charles; R Grady, Sharon; Loi, Barbara; Fucile, Sergio; Fasoli, Francesca; Zoli, Michele; Tasso, Bruno; Sparatore, Fabio; Clementi, Francesco; Gotti, Cecilia
Choline and nicotine increase glioblastoma cell proliferation by binding and activating alpha 7-and alpha 9-containing nicotinic receptors
2021 Pucci, Susanna; Fasoli, Francesca; Moretti, Milena; Benfante, Roberta; Di Lascio, Simona; Viani, Paola; Daga, Antonio; Gordon Thomas, J; Mcintosh, Michael; Zoli, Michele; Clementi, Francesco; Gotti, Cecilia
Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus
2005 Bohr IJ; Ray MA; McIntosh JM; Chalon S; Guilloteau D; McKeith IG; Perry RH; Clementi F; Perry EK; Court JA; Piggott MA
Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-Delta2-isoxazoline derivatives as potent and selective agonists of alpha7 nicotinic acetylcholine receptors.
2011 Dallanoce C; Magrone P; Matera C; Frigerio F; Grazioso G; De Amici M; Fucile S; Piccari V; Frydenvang K; Pucci L; Gotti C; Clementi F;De Micheli; C
Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice
2015 Ponzoni, L; Moretti, M; Sala, M; Fasoli, F; Mucchietto, V; Lucini, V; Cannazza, G; Gallesi, G; Castellana, Cn; Clementi, F; Zoli, M; Gotti, C; Braida, D
Engineering of alpha-conotoxin MII-derived peptides with increased selectivity for native alpha 6 beta 2*nicotinic acetylcholine receptors
2011 Pucci, Luca; Grazioso, Giovanni; Dallanoce, Clelia; Rizzi, Luca; De Micheli, Carlo; Clementi, Francesco; Bertrand, Sonia; Bertrand, Daniel; Longhi, Renato; De Amici, Marco; Gotti, Cecilia
Epiboxidine and novel-related analogues: a convenient synthetic approach and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.
2008 Rizzi L; Dallanoce C; Matera C; Magrone P; Pucci L; Gotti C; Clementi F; De Amici M
Evidence of a dual mechanism of action underlying the anti-proliferative and cytotoxic effects of ammonium-alkyloxy-stilbene-based alpha7- and alpha9-nicotinic ligands on glioblastoma cells
2022 Pucci S.; Bolchi C.; Bavo F.; Pallavicini M.; De Palma C.; Renzi M.; Fucile S.; Benfante R.; Di Lascio S.; Lattuada D.; Bessereau J.L.; D'Alessandro M.; Risson V.; Zoli M.; Clementi F.; Gotti C.
Expression of nigrostriatal alpha6 containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta3 subunit gene deletion.
2005 Gotti C; Moretti M; Clementi F; Riganti L; McIntosh M; Collins AC ; Marks J; Whitaeker P.
Expression of the alpha7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS.
2011 Benfante, R; Antonini, ; R, A; De Pizzol, M; Gotti, C; Clementi, F; Locati, M; Fornasari, DIEGO MARIA MICHELE; D,
Extremely low-frequency electromagnetic field (ELF-EMF) does not affect the expression of alpha3, alpha5 and alpha7 nicotinic receptor subunit genes in SH-SY5Y neuroblastoma cell line.
2006 Ruth Adele Antonini; Roberta Benfante; Cecilia Gotti; Milena Moretti; Niels Kuster; Juergen Schuderer; Francesco Clementi;Diego Fornasari
Glutamatergic reinnervation and assembly of glutamatergic synapses in adult rat skeletal muscle occurs at cholinergic endplates.
2009 Francolini M.; Brunelli G.; Cambianica I.; Barlati S.; Barbon A.; La Via L.; Guarneri B.; Boroni F.; Lanzillotta A.; Ettorre M.; Buffelli M.; Spano P.; Clementi F.; Pizzi M.
Heterogeneity and complexity of native brain nicotinic receptors.
2007 Gotti, C; Moretti, M; Gaimarri, A; Zanardi, A; Clementi, F; Zoli, M
Heterogeneity and selective targeting of nAChR subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus. Identification of a new native nAChR subtype (apha3beta2) (alpha5 or (beta3) enriched in retinocollicular afferents
2005 Gotti C; Moretti M ; Zanardi A; Gaimarri A; Champtiaux N; Changeux JP; Whitaker P; Clementi F; Zoli M.
In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of ?4?2 nicotinic receptors in cortex and thalamus
2016 Fasoli, F; Moretti, M; Zoli, M; Pistillo, F; Crespi, A; Clementi, F; Mc ClureBegley, T; Marks, Mj; Gotti, C